[1] Palaka E,Grandy S,van Haalen H. The impact of CKD anaemia on patients:Incidence,risk factors,and clinical outcomes-A systematic literature review[J]. Int J Nephrol,2020,2020:7692376. [2] 张亭亭,许贤荣,许静,等.老年慢性肾衰竭持续性血液透析患者自我感受负担与心理脆弱程度的关系[J].中国医药导报,2023,20(24):64-68. [3] 吕晴,陈卫东,刘磊.维持性血液透析患者肾性贫血的多因素分析及相关性研究[J].中华全科医学,2021,19(5):871-874. [4] 王伟铭. 糖尿病肾脏疾病肾性贫血认识与管理中国专家共识(2023年版)解读[J].内科理论与实践,2023,18(3):137-140. [5] Heras-Benito M.Renal anemia:Current treatments and emerging molecules[J]. Rev Clin Esp (Barc),2023,223(7):433-439. [6] 刘海飞,赵晓倩,李兆婷,等.老年维持性血液透析病人肾性贫血现状调查及影响因素分析[J].实用老年医学,2022,36(4):345-349. [7] Shiferaw WS,Akalu TY,Aynalem YA.Risk factors for anemia in patients with chronic renal failure:A systematic review and Meta-analysis[J]. Ethiop J Health Sci,2020,30(5):829-842. [8] 葛均波,徐永健.内科学[M].8版.北京:人民卫生出版社,2013:524-529. [9] 高永祥,张晋昕. Logistic回归分析的样本量确定[J]. 循证医学,2018(2):122-124. [10] 方积乾. 卫生统计[M].7版.北京:人民卫生出版社,2018:691-693. [11] 仇思傲,杨家慧,王蓓.维持性血液透析患者营养状况及影响因素研究[J].华南预防医学,2022,48(1):81-83. [12] Hanna RM,Streja E,Kalantar-Zadeh K.Burden of anemia in chronic kidney disease:Beyond Erythropoietin[J]. Adv Ther,2021,38(1):52-75. [13] Kaneko T,Kodani E,Fujii H,et al.Anemia and atrial fibrillation as independent risk factors for new-onset chronic kidney disease:The TAMA-MED Project-CKD and AF[J]. Clin Kidney J,2021,14(10):2221-2226. [14] 中华医学会肾脏病学分会肾性贫血诊断和治疗共识专家组.肾性贫血诊断与治疗中国专家共识(2018 修订版)[J].中华肾脏病杂志,2018,34(11):860-866. [15] 郭友志. 大剂量促红细胞生成素对血液透析患者肾性贫血的治疗效果及对血清铁蛋白叶酸水平的影响[J].山西医药杂志,2021,50(10):1668-1670. [16] 王颜,伍静,苗起芬,等.维持性血液透析患者血清OPN和iPTH 水平与血管钙化的相关性研究[J].中国实验诊断学,2021,25(8):1166-1168. [17] Matsushita K,Ballew SH,Wang AY,et al.Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease[J]. Nat Rev Nephrol,2022,18(11):696-707. [18] Yin S,Du Y,Guo Y,et al.Multifactorial analysis of renal anemia-associated substandard hemoglobin levels and prevalence of anemia in patients on maintenance hemodialysis in Liaoning Province:A cross-sectional study[J]. Ann Palliat Med,2022,11(12):3743-3754. [19] Yin P,Wu Q,Shou L,et al.Risk factors for anemia in patients with chronic kidney disease:A protocol for systematic review and meta-analysis[J]. Medicine (Baltimore),2021,100(40):e27371. [20] 唐珑,赵文景,郑桂敏,等.慢性肾脏病3~5期非透析患者肾性贫血与铁缺乏的相关性及影响因素分析[J].中国医刊,2022,57(9):1010-1013. [21] Estes JP,Chen Y,Şentürk D,et al.Profiling dialysis facilities for adverse recurrent events[J]. Stat Med,2020,39(9):1374-1389. [22] 李霞,陈育青.影响维持性血液透析患者促红细胞生成素抵抗的因素分析[J].重庆医学,2022,51(9):1554-1557. [23] Bossola M,Di Stasio E,Monteburini T,et al.Intensity,duration,and frequency of post-dialysis fatigue in patients on chronic haemodialysis[J]. J Ren Care,2020,46(2):115-123. [24] 苏森森,许钟镐.影响肾性贫血治疗效果的因素[J].中国实用内科杂志,2020,12(22):916-919. [25] 周亮亮,张凤芹.慢性肾功能衰竭患者连续性血液透析治疗后2年内死亡的危险因素及列线图预测模型的构建[J].广西医学,2023,45(12):1432-1438. [26] 李晔,马春园,徐燕.苏州市第九人民医院慢性肾脏病贫血状况的单中心横断面调查[J].分子诊断与治疗杂志,2022,14(12):2119-2124. [27] Estrela GR,Freitas-Lima LC,Budu A,et al.Chronic kidney disease induced by cisplatin,folic acid and renal ischemia reperfusion induces anemia and promotes GATA-2 activation in mice[J]. Biomedicines,2021,9(7):769. [28] Schop A,Stouten K,Riedl JA,et al.The accuracy of mean corpuscular volume guided anaemia classification in primary care[J]. Fam Pract,2021,38(6):735-739. |